发明名称 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF
摘要 The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.
申请公布号 US2012329715(A1) 申请公布日期 2012.12.27
申请号 US201213594313 申请日期 2012.08.24
申请人 GREIG NIGEL;EGAN JOSEPHINE;DOYLE MAIRE;HOLLOWAY HAROLD;PERRY TRACY ANN;THE GOV. OF THE US, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH & HUMAN SERVICES 发明人 GREIG NIGEL;EGAN JOSEPHINE;DOYLE MAIRE;HOLLOWAY HAROLD;PERRY TRACY ANN
分类号 A61K38/26;A61K38/28;A61K38/00;A61P3/10;A61P9/10;A61P19/08;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C07K14/47;C07K14/575;C07K14/605 主分类号 A61K38/26
代理机构 代理人
主权项
地址